首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Drug development research

缩写:DRUG DEVELOP RES

ISSN:0272-4391

e-ISSN:1098-2299

IF/分区:4.2/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1366
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Dinesh K Chellappan,Lim W Yee,Kong Y Xuan et al. Dinesh K Chellappan et al.
Neutrophils are essential effector cells of immune system for clearing the extracellular pathogens during inflammation and immune reactions. Neutrophils play a major role in chronic respiratory diseases. In respiratory diseases such as asth...
Mariana L Garcia,Andrew A de Oliveira,Renata V Bueno et al. Mariana L Garcia et al.
Malaria is an infectious disease caused by protozoan parasites of the genus Plasmodium and transmitted by Anopheles spp. mosquitos. Due to the emerging resistance to currently available drugs, great efforts must be invested in discovering n...
Joshua A Kulas,Thaddeus K Weigel,Heather A Ferris Joshua A Kulas
Diabetes disrupts organs throughout the body including the brain. Evidence suggests diabetes is a risk factor for Alzheimer's disease (AD) and neurodegeneration. In this review, we focus on understanding how diabetes contributes to the prog...
Diego Benítez,Estefania Dibello,Mariana Bonilla et al. Diego Benítez et al.
African trypanosomiasis is a major problem for human and animal health in endemic countries, where it threatens millions of people and affects economic development. New drugs are needed to overcome the toxicity, administration, low efficacy...
Daniel Conole,Yi-Tai Chou,Anastasia Patsiarika et al. Daniel Conole et al.
Neuropilin-1 (NRP1) is emerging as an important molecule in immune signaling where it has been shown to modulate the actions of TGF-β1 in macrophages and regulatory T cells. The development of cost-effective and reliable assays for NRP1 bi...
Emine Alarçin,Çağlar Demirbağ,Seher Karsli-Ceppioglu et al. Emine Alarçin et al.
Oxaceprol is well-defined therapeutic agent as an atypical inhibitor of inflammation in osteoarthritis. In the present study, we aimed to develop and characterize oxaceprol-loaded poly-lactide-co-glycolide (PLGA) nanoparticles for intra-art...
Mthanna AlKhalil,Yusuf Al-Hiari,Violet Kasabri et al. Mthanna AlKhalil et al.
The repurposing of safe therapeutic drugs has emerged as an alternative approach to rapidly identify effective, safe, and conveniently available therapeutics to treat/prevent cancer. Therefore, it was hypothesized that acidic chelator drugs...
Eleni Kavetsou,Annita Katopodi,Letta Argyri et al. Eleni Kavetsou et al.
Eighteen 3-aryl-5-substituted-coumarins-six 5-acetyloxy-derivatives, six 5-hydroxy-derivatives, and six 5-geranyloxy-derivatives-were synthesized, structurally characterized and their antioxidant activity, lipoxygenase inhibitory ability, a...
Nermin S Ahmed,Jannette Wober Nermin S Ahmed
Tamoxifen (TAM) is currently the endocrine treatment of choice for all stages of breast cancer; it has proven success in ER positive and ER negative patients. TAM is activated by endogenous CYP450 enzymes to the more biologically active met...